Aurora Cannabis (ACB) Revenue Growth (1y) (2018 - 2026)
Aurora Cannabis (ACB) Revenue Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.20 Bn | 21.05 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn | 14.92% |
| 10 | Aurora Cannabis | 155.96 Mn | 70.72 Mn | 21.72 Mn | 10.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.48% |
| Dec 31, 2025 | 31.29% |
| Sep 30, 2025 | -49.10% |
| Jun 30, 2025 | -64.45% |
| Mar 31, 2025 | 53.45% |
| Dec 31, 2024 | 33.52% |
| Sep 30, 2024 | -69.21% |
| Jun 30, 2024 | -56.36% |
| Dec 31, 2023 | -59.95% |
| Sep 30, 2023 | 450.94% |
| Jun 30, 2023 | 1,060.07% |
| Dec 31, 2022 | 145.66% |
| Sep 30, 2022 | 59.27% |
| Jun 30, 2022 | 125.60% |
| Mar 31, 2022 | -8.64% |
| Dec 31, 2021 | -7.40% |
| Sep 30, 2021 | -6.17% |
| Jun 30, 2021 | -300.49% |
| Mar 31, 2021 | -22.63% |
| Dec 31, 2020 | 22.31% |